© 2022 MJH Life Sciences™ and Ophthalmology Times. All rights reserved.
All News
Pipeline reveals bright future for combating diabetic eye disease
December 01, 2022
Despite the latest advances in anti-VEGF therapy, a small group of patients do not achieve improved vision. Ophthalmologists are looking for options.
Genetics of glaucoma
December 01, 2022
Janey Wiggs, MD, PhD, associate chief of Ophthalmology Clinical Research at Massachusetts Eye & Ear discusses genetics of glaucoma, providing an overview of what is known about genes and gene mutations that can cause or contribute to glaucoma.
Visual outcomes after secondary IOL implantation in aphakic children
December 01, 2022
According to physicians, patients who do not undergo second procedure are more likely to develop glaucoma.
Re-Vana Therapeutics raises $11.9 million in Series A financing for development of ophthalmic therapeutics
November 30, 2022
Re-Vana has demonstrated that its platform can achieve 6 months or greater sustained delivery of an anti-VEGF biologic at therapeutically-relevant levels with high drug loading, controlled burst release, and a favorable degradation profile.
Harrow and iOR Partners expand national product supply agreement
November 30, 2022
The deal will provide Harrow’s entire formulary compounded ophthalmic products to iOR Partners’ expanding office-based surgery locations across the United States.
OWL, WIO to co-host networking reception during Hawaiian Eye
November 29, 2022
The groups invite those attending the annual conference to join them at their event on Monday, January 16, which is free to OWL and WIO members.
OC-01 0.03 mg nasal spray is effective against dry eye disease regardless of menopausal status
November 29, 2022
According to investigators, the risk for the development of dry eye disease is greater in postmenopausal women compared with those who have not reached menopause as a result of hormonal dysregulation of the ocular secretory glands.
Making progress in RP by combining gene therapy and medical device
November 28, 2022
Investigators who are examining end-stage disease see significant visual recovery in 2 patients.
Remote monitoring device detects AMD progression
November 27, 2022
Patients surveyed say the handheld tool proved to be comfortable and easy to use.
Gene therapy trial highlights RPGR-associated X-linked RP
November 25, 2022
The therapy offers improved retinal sensitivity, visual function, as well as improvements in mobility.